TELA Bio, Inc. (TELA) Stock: Dividends & Earnings

Company Overview:

Market Cap: $71.19M

Trailing PE: N/A

FWD PE: —

Payout Ratio (TTM): —

52-Week Range: $0.50 - $1.60

6.9 Year TELA Performance Metrics:

Total Return (with DRIP): -90.7% (-29.14% CAGR)

Total Return (no DRIP): -90.7% (-29.14% CAGR)

Share Price: -90.7% (-29.14% CAGR)

Yield on Cost (with DRIP): —

Total Invested: $10,000

Total Value (with DRIP): $929

Total Return $ (with DRIP): -$9,071

TELA Total Return

1M 3M 6M YTD 1Y 3Y 5Y 10Y

TELA Price Chart

1M 3M 6M YTD 1Y 3Y 5Y 10Y All

Unlock All Reports & Research Dividend Stocks like a BOSS!

Save 25% with annual plan (3 Months Free)

Pro

$171 ($14.25/mo) $102.60/yr ($8.55/mo)

7-day free trial

Unlimited Portfolio Tracker
Portfolio - Lots/Sales/Dividends
Portfolio Auto-DRIP
Stock Fundamentals
DCF valuation modeling
Compare Stocks Side-by-Side
Revenue & EPS Estimates

Try it free for 7 days

You save $125.40 (55%)

Projected Future Returns & Dividends for TELA

Based on past 6.9-year performance, here are TELA growth metrics:

Share price CAGR of -29.14%
Dividend CAGR of +0%

Using TELA CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, should grow as follows:

	TELA (DRIP)	TELA - No DRIP
Current Price	$1.24	$1.24
Start Shares	8,064.52	8,064.52
Start Value	$10,000	$10,000

After 10 years:
Final Share Count	8,064.52	8,064.52
Dividends Payment	$0.00	$0.00
Annual Dividends	$0	$0
Yield on cost	0.00%	0.00%
Share Price	$0.04	$1.24
Total Dividends	$0	$0
Final Value	$319	$10,000

Estimated Future Value + Dividends - TELA

NOTE: Above numbers are our estimate based on TELA's Dividend and Price CAGR over past 6.9 years. These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.

We cannot guarantee that your actual returns will meet these estimates.

Get the best Dividend Stock Research Tools:

Save 25% with annual plan (3 Months Free)

Pro

$171 ($14.25/mo) $102.60/yr ($8.55/mo)

7-day free trial

Unlimited Portfolio Tracker
Portfolio - Lots/Sales/Dividends
Portfolio Auto-DRIP
Stock Fundamentals
DCF valuation modeling
Compare Stocks Side-by-Side
Revenue & EPS Estimates

Try it free for 7 days

You save $125.40 (55%)

Company Info

TELA Bio, Inc. (TELA) had its IPO on , and is traded on NASDAQ stock exchange.

TELA Bio, Inc. is a commercial-stage medical technology company focused on soft-tissue reconstruction solutions for surgeons and healthcare providers. The company develops and markets reinforced tissue matrix products designed for hernia repair, abdominal wall reconstruction, and plastic and reconstructive surgery, with an emphasis on preserving and restoring the patient’s own anatomy. Its OviTex portfolio includes products for open, laparoscopic, and robotic procedures, as well as configurations tailored to different surgical needs in general surgery and reconstructive care. TELA Bio also supports applications that aim to reduce reliance on permanent synthetic materials while leveraging the body’s natural healing response. Headquartered in Malvern, Pennsylvania, TELA Bio serves the medical device market through products that address unmet needs in modern soft-tissue repair.

TELA website: https://www.telabio.com